Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ibrutinib
Biotech
AbbVie pens Imbruvica pact to support pivotal Oncternal trial
AbbVie has helped Oncternal move a step closer to the start of a phase 3 trial by agreeing to supply its BTK inhibitor ibrutinib for use in the study.
Nick Paul Taylor
Jul 15, 2022 9:55am
Kymera targets protein degradation to treat lymphoma
Jun 19, 2019 10:31am
New discoveries in Lyme disease and cancer—News of Note
Feb 5, 2018 5:00pm
Redx sells cancer drug to Loxo to escape debt crisis
Jul 31, 2017 8:29am
